Personalising care in oesophageal cancer care with liquid biopsy.

Bruno De PaulaBruno Henrique Rala de Paula

Published in: British journal of cancer (2021)

The advent of ctDNA has the potential to be a game changer in some cancers, but limited data is available in oesophago-gastric cancers (OGC). The prognostic value of ctDNA and the potential for false positive results due to clonal haematopoiesis of indeterminate potential (CHIP) was recently reported in operable OGC.

Keyphrases

healthcare
human health
high throughput
big data
circulating tumor
climate change
young adults
deep learning
chronic pain
data analysis
virtual reality